Enhancing venetoclax activity in hematological malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancing venetoclax activity in hematological malignancies

Published:2020-07-02 Issue:7 Volume:29 Page:697-708
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Satta Toshihisa¹,Grant Steven¹²³⁴^ORCID

Affiliation:

1. Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, USA

2. Department of Biochemistry, Virginia Commonwealth University, Richmond, USA

3. Department of Pharmacology, Virginia Commonwealth University, Richmond, USA

4. Department of Molecular and Human Genetics, Virginia Commonwealth University, Richmond, USA

Funder

Department of Health and Human Service, National Institutes of Health, National Cancer Institute

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1789588

Reference133 articles.

1. Mitochondria—Judges and Executioners of Cell Death Sentences

2. Finally, An Apoptosis-Targeting Therapeutic for Cancer

3. An inhibitor of Bcl-2 family proteins induces regression of solid tumours

4. ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells

5. Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies;Discover Oncology;2024-07-26

2. Myeloid Targeted Human MLL-ENL and MLL-AF9 Induces cdk9 and bcl2 Expression in Zebrafish Embryos;PLOS Genetics;2024-06-03

3. Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review;Frontiers in Pharmacology;2023-11-06

4. Translocation Tales: Unraveling the MYC Deregulation in Burkitt Lymphoma for Innovative Therapeutic Strategies;Lymphatics;2023-07-11

5. Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin;Journal of Chemotherapy;2023-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3